Finance

Lists
600998:SHA
Jointown Pharmaceutical Group Co Ltd
4,93 CNY
-1,79%
(-0,090) 1D
16 ოქტ, 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600998...
Open
5,02 CNY
High
5,08 CNY
Low
4,88 CNY
Mkt. cap
24,86 მლრდ.
Avg. vol.
33,74 მლნ.
Volume
44,94 მლნ.
Dividend
4,06%
Quarterly dividend
0,05 CNY
Ex-dividend date
8 ივნ. 2026
P/E ratio
12,56
52-wk high
5,84 CNY
52-wk low
4,48 CNY
EPS
0,39 CNY
Shares outstanding
1,88 მლრდ.
No. of employees
30 ათ.
Open
5,02 CNY
High
5,08 CNY
Low
4,88 CNY
Mkt. cap
24,86 მლრდ.
Avg. vol.
33,74 მლნ.
Volume
44,94 მლნ.
Dividend
4,06%
Quarterly dividend
0,05 CNY
Ex-dividend date
8 ივნ. 2026
P/E ratio
12,56
52-wk high
5,84 CNY
52-wk low
4,48 CNY
EPS
0,39 CNY
Shares outstanding
1,88 მლრდ.
No. of employees
30 ათ.
News stories
From web sources and news partners
Profile
Jointown Pharmaceutical Group Co., Ltd. is a publicly traded multinational healthcare services company. By revenue, it is the largest medical company in China that is not state-owned. It is also the 4th largest overall. Its global headquarters are in Wuhan, China and its international headquarters are in Los Angeles, California. The company specializes in the distribution of pharmaceuticals and medical products, distributing more than 510,000 products. The company also manufactures products, including gloves, surgical masks, medical equipment and medications. In addition, it operates the largest network of medical warehouses in China. It is one of the largest in the world, at over 44 million square feet. The company has over 400 subsidiaries and provides medical products to all 31 provinces in mainland China. Wikipedia
About Jointown Pharmaceutical Group Co Ltd
CEO-
Employees29,9 ათ.
Founded2000
Headquarters-
SectorHealth care provider
Websitejointown.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
38,22 მლრდ.
42,06 მლრდ.
44,78 მლრდ.
42,50 მლრდ.
Cost of goods sold
35,00 მლრდ.
38,94 მლრდ.
41,44 მლრდ.
39,12 მლრდ.
Cost of revenue
35,00 მლრდ.
38,94 მლრდ.
41,44 მლრდ.
39,12 მლრდ.
Research and development expenses
31,00 მლნ.
31,05 მლნ.
24,25 მლნ.
35,77 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,07 მლრდ.
2,21 მლრდ.
2,07 მლრდ.
2,24 მლრდ.
Operating expense
2,18 მლრდ.
2,54 მლრდ.
2,37 მლრდ.
2,45 მლრდ.
Total operating expenses
37,17 მლრდ.
41,49 მლრდ.
43,81 მლრდ.
41,57 მლრდ.
Operating income
1,05 მლრდ.
577,21 მლნ.
971,28 მლნ.
922,06 მლნ.
Other non operating income
-10,19 მლნ.
-23,03 მლნ.
-15,38 მლნ.
-57,14 მლნ.
EBT including unusual items
706,81 მლნ.
590,98 მლნ.
762,47 მლნ.
810,81 მლნ.
EBT excluding unusual items
868,16 მლნ.
402,66 მლნ.
702,61 მლნ.
619,67 მლნ.
Income tax expense
148,37 მლნ.
258,61 მლნ.
167,28 მლნ.
213,41 მლნ.
Effective tax rate
20,99%
43,76%
21,94%
26,32%
Other operating expenses
7,64 მლნ.
209,56 მლნ.
45,26 მლნ.
169,00 მლნ.
Net income
529,89 მლნ.
279,41 მლნ.
733,16 მლნ.
467,41 მლნ.
Net profit margin
1,39%
0,66%
1,64%
1,10%
Earnings per share
0,10
0,05
0,11
0,08
Interest and investment income
65,37 მლნ.
122,28 მლნ.
65,73 მლნ.
31,49 მლნ.
Interest expense
-245,91 მლნ.
-262,58 მლნ.
-319,03 მლნ.
-279,26 მლნ.
Net interest expenses
-180,54 მლნ.
-140,30 მლნ.
-253,30 მლნ.
-247,77 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,22 მლრდ.
728,70 მლნ.
1,12 მლრდ.
1,11 მლრდ.
Gain or loss from assets sale
-238,51 მლნ.
244,27 მლნ.
-
20,61 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები